Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System ...

Protagonist Therapeutics, Inc. (“Protagonist”) ( NASDAQ:PTGX) and Takeda ( TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 VERIFY study, in which phlebotomy-dependent ...

All mandatory test cases and optional Android Key attestation test cases of FIDO2 Test Tools provided by FIDO Alliance are passed. WebAuthn4J uses a Gradle based build system. In the instructions ...

Eugene School District 4J has joined a lawsuit against Department of Education. The district joins a teachers union and the American Sociological Association in the case. Eugene School District 4J ...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported financial results for the fourth quarter and year ended December 31, 2024 and provided a corporate update.

Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell Stoke’s experimental treatment for Dravet syndrome, a severe form of epilepsy, outside the U.S., the comp ...

Ko­jin Ther­a­peu­tics, a start­up at­tempt­ing to de­vel­op new treat­ments us­ing pro­grammed cell death, left last month’s JP Mor­gan Health­care Con­fer­ence in a bind.

Again, the three metro school districts were consistent with their weather plans: Eugene School District 4J, Springfield Public Schools, and Bethel School District all have a two-hour delayed ...

Crispr Therapeutics AG reported significant revenue declines in Q4 and FY24 due to reduced collaboration revenues, but maintains strong financial health with $298m cash and $1.6bn in marketable ...